Información del producto
BDA 366 is a drug candidate that inhibits the growth of cancer cells, specifically chronic lymphocytic leukemia. The molecular target of BDA 366 is a hydrophobic region in the center of the protein. This drug has been shown to induce apoptosis in hematopoietic cells, with no effect on normal cells. BDA 366 is being developed as an anticancer agent and has shown promising results in animal models. It was also shown to have synergistic effects when combined with other drugs such as abt-199 and pro-apoptotic proteins.
Propiedades químicas
Consulta técnica sobre: 3D-SFA64519 BDA 366
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
